{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Drug development", "Epigenetics", "HDAC6", "Vitamin K(3)", "Zebrafish"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32721508", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bcp.2020.114176", "S0006-2952(20)30412-3"], "Journal": {"ISSN": "1873-2968", "JournalIssue": {"Volume": "180", "PubDate": {"Year": "2020", "Month": "Oct"}}, "Title": "Biochemical pharmacology", "ISOAbbreviation": "Biochem Pharmacol"}, "ArticleTitle": "Vitamin K<sub>3</sub> chloro derivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis, and inhibits aggresome formation in hepatocellular carcinoma cells.", "Pagination": {"StartPage": "114176", "MedlinePgn": "114176"}, "Abstract": {"AbstractText": ["Epigenetics plays a vital role in regulating gene expression and determining the specific phenotypes of eukaryotic cells. Histone deacetylases (HDACs) are important epigenetic regulatory proteins effecting multiple biological functions. Particularly, HDAC6 has become a promising anti-cancer drug target because of its regulation of cell mobility, protein trafficking, degradation of misfolded proteins, cell growth, apoptosis, and metastasis. In this study, we identified one out of six vitamin K<sub>3</sub> derivatives, VKT-2, as HDAC6 inhibitor using molecular docking and cell viability assays in HDAC6-overexpressing HuH-7 cancer cells. Microscale thermophoresis and HDAC6 enzymatic assays revealed that VKT-2 bound to HDAC6 and inhibited its function. We further identified its cytotoxic activity. VKT-2 hyperacetylated HDAC6 substrates and disturbed tubulin integrity leading to significant inhibition of tumor migration in both HuH-7 spheroids and U2OS-GFP-\u03b1-tubulin cells. Moreover, VKT-2 induced autophagic and apoptotic cell death in HuH-7, while aggresome formation was restrained after VKT-2 treatment. A HuH-7 cell-xenograft model in zebrafish larvae provided evidence that VKT-2 inhibited the tumor growth in vivo. To best of our knowledge, it is the first time to demonstrate that vitamin k<sub>3</sub> derivatives (VKT-2) inhibits HDAC6 in solid tumor cells. These unique findings suggested that VKT-2 is a promising anti-cancer agent targeting HDAC6."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany; Department of Molecular Biology, Faculty of Medical Laboratory Science, Al-Neelain University, Khartoum, Sudan."}], "LastName": "Dawood", "ForeName": "Mona", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany; Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany."}], "LastName": "Elbadawi", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MicroCombiChem GmbH, Wiesbaden, Germany."}], "LastName": "Fleischer", "ForeName": "Edmond", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MicroCombiChem GmbH, Wiesbaden, Germany."}], "LastName": "Klinger", "ForeName": "Anette", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Organic Chemistry, University of W\u00fcrzburg, Am Hubland, 97074 W\u00fcrzburg, Germany."}], "LastName": "Bringmann", "ForeName": "Gerhard", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "AIT Austrian Institute of Technology GmbH, Preclinical Molecular Imaging, Seibersdorf, Austria."}], "LastName": "Kuntner", "ForeName": "Claudia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310053, China."}], "LastName": "Shan", "ForeName": "Letian", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. Electronic address: efferth@uni-mainz.de."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biochem Pharmacol", "NlmUniqueID": "0101032", "ISSNLinking": "0006-2952"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Histone Deacetylase Inhibitors"}, {"RegistryNumber": "723JX6CXY5", "NameOfSubstance": "Vitamin K 3"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "HDAC6 protein, human"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "Histone Deacetylase 6"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Autophagy"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Cell Aggregation"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Histone Deacetylase 6"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Histone Deacetylase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Vitamin K 3"}, {"QualifierName": ["methods"], "DescriptorName": "Xenograft Model Antitumor Assays"}, {"QualifierName": [], "DescriptorName": "Zebrafish"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "4", "Day": "10"}, {"Year": "2020", "Month": "7", "Day": "21"}, {"Year": "2020", "Month": "7", "Day": "22"}, {"Year": "2020", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32721508", "10.1016/j.bcp.2020.114176", "S0006-2952(20)30412-3"]}}]}